Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate two pharmacotherapeutic approaches to sleep induction, both of which have been shown to be effective hypnotics, but may have unique side effect profiles. These profiles may have markedly different impacts on performance in a military setting. In this randomized, double-blind, placebo controlled study, the side effects of these drugs will be compared - suvorexant, a dual orexin receptor antagonist and zolpidem, a non-benzodiazepine gamma-aminobutyric acid (GABA) A agonist - in healthy controls comparable in age and gender to the target military population.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Performance Enhancing Product Use

NCT number NCT04273776
Study type Interventional
Source Walter Reed Army Institute of Research (WRAIR)
Contact
Status Enrolling by invitation
Phase Early Phase 1
Start date December 1, 2019
Completion date December 12, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04203992 - Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes N/A
Enrolling by invitation NCT04474015 - Optimizing Volunteer Comfort for Transcranial Electrical Stimulation (TES): An Assessment N/A
Completed NCT06112210 - Effect of Hyperbaric Oxygen Therapy N/A
Not yet recruiting NCT05845255 - Validation of the Mjn-SERAS Performance
Recruiting NCT06371521 - Ergogenic Effects of Sportlegs Phase 1
Completed NCT04230226 - Acute Study on Muscle Soreness, Damage, and Performance N/A
Completed NCT06464120 - Investigating the Post-Activation Performance Enhancement Effects on Skeletal Muscles Under Varied Loading Conditions N/A
Recruiting NCT04290819 - Effect of Creatine and Caffeine on Muscle Performance N/A
Completed NCT05295836 - Effects of Acute Glycerol Ingestion on Performance, Metabolic and Biochemical Markers in International Athletes N/A
Completed NCT04230824 - Chronic Study on Body Composition, Training, Performance, and Recovery N/A